References
- Beal MF, Brouillet E, Jenkins BG, et al. (1993). Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J Neurosci 13:4181–92
- Beal MF. (1998). Mitochondrial dysfunction in neurodegenerative diseases. Biochim Biophys Acta 1366:211–23
- Bihaqi SW, Sharma M, Singh AP, Tiwari M. (2009). Neuroprotective role of Convolvulus pluricaulis on aluminium induced neurotoxicity in rat brain. J Ethnopharmacol 124:409–15
- Bihaqi SW, Singh AP, Tiwari M. (2011). In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats. Indian J Pharmacol 43:520–5
- Bihaqi SW, Singh AP, Tiwari M. (2012). Supplementation of Convolvulus pluricaulis attenuates scopolamine-induced increased tau and amyloid precursor protein (AbetaPP) expression in rat brain. Indian J Pharmacol 44:593–8
- Bisht NPS, Singh R, Bansal RK, Singh P. (1978). Isolation of n-triacontane, aliphatic alcohols and sitosterols from Convolvulus microphyllus Sieb. Organische Chemie 33B:249
- Borlongan CV, Koutouzis TK, Sanberg PR. (1997). 3-Nitropropionic acid animal model and Huntington's disease. Neurosci Biobehav Rev 21:289–93
- Butterfield DA, Howard BJ, LaFontaine MA. (2001). Brain oxidative stress in animal models of accelerated aging and the age-related neurodegenerative disorders, Alzheimer's disease and Huntington's disease. Curr Med Chem 8:815–28
- Chowdhary MR, Kapoor RC. (1986). Chemical constituents of Convolvulus microphyllus. Curr Sci 55:917–18
- Chunekar KC, Pandey GS. (2002). Bhavaprakasa Nighantu – Indian Materia Medica of Sri Bhavamisra. Varanasi: Chaukhambha Bharati Academy
- Coles CJ, Edmondson DE, Singer TP. (1979). Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 254:5161–7
- Deshpande SM, Srivastava DN. (1969). Chemical studies of Convolvulus puricaulis. I. J Indian Chem Soc 46:759–60
- Dhingra D, Valecha R. (2007). Evaluation of the antidepressant-like activity of Convolvulus pluricaulis Choisy in the mouse forced swim and tail suspension tests. Med Sci Monit 13:BR155–61
- Duckworth EA, Koutouzis TK, Borlongan CV, et al. (1999). Rats receiving systemic 3-nitropropionic acid demonstrate impairment of memory in Morris water maze. Psychobiology 27:561–6
- Ellman GL. (1959). Tissue sulfhydryl groups. Arch Biochem Biophys 82:70–7
- Fatokun AA, Smith RA, Stone TW. (2008). Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons. Brain Res 1215:200–7
- Gornall AG, Bardawill CJ, David MM. (1949). Determination of serum proteins by means of the biuret reaction. J Biol Chem 177:751–66
- Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126:131–8
- Joshi JP, Kamat JP, Mohan H, et al. (2004). Antioxidant effects of Convolvulus pluricalus in rat brain mitochondria against oxidative damage induced by gamma radiation and photosensitization. BARC Newslett 249:183–7
- Kalonia H, Kumar P, Kumar A. (2010). Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats. Eur J Pharmacol 634:46–52
- Kalonia H, Kumar P, Kumar A. (2011). Licofelone attenuates quinolinic acid induced Huntington like symptoms: Possible behavioral, biochemical and cellular alterations. Prog Neuropsychopharmacol Biol Psychiatry 35:607–15
- Kapadia NS, Acharya NS, Acharya SA, Shah MB. (2006). Use of HPTLC to establish a distinct chemical profile for Shankhpushpi and for quantification of scopoletin in Convolvulus pluricaulis Choisy and in commercial formulations of Shankhpushpi. JPC 19:195–9
- Kono Y. (1978). Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 186:189–95
- Kumar P, Kalonia H, Kumar A. (2009). Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats. J Asian Nat Prod Res 11:439–50
- Kumar P, Kalonia H, Kumar A. (2011). Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: Protective effect of licofelone. Br J Pharmacol 164:644–54
- Kumar P, Kumar A. (2009a). Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: A novel nitric oxide mechanism. Food Chem Toxicol 47:2522–30
- Kumar P, Kumar A. (2009b). Neuroprotective effect of cyclosporine and FK506 against 3-nitropropionic acid induced cognitive dysfunction and glutathione redox in rat: Possible role of nitric oxide. Neurosci Res 63:302–14
- Kumar P, Kumar A. (2009c). Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 33:100–8
- Kumar P, Kumar A. (2009d). Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: Possible behavioural, biochemical and cellular alterations. Eur J Pharmacol 615:91–101
- Kumar P, Kumar A. (2010). Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington’s like symptoms in rats: Possible role of nitric oxide. Behav Brain Res 206:38–46
- Kumar P, Padi SS, Naidu PS, Kumar A. (2006a). Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: Possible neuroprotective mechanisms. Behav Pharmacol 17:485–92
- Kumar P, Padi SS, Naidu PS, Kumar A. (2007a). Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: Possible antioxidant mechanisms. Fundam Clin Pharmacol 21:297–306
- Kumar P, Padi SS, Naidu PS, Kumar A. (2007b). Possible neuroprotective mechanisms of curcumin in attenuating 3-nitropropionic acid-induced neurotoxicity. Methods Find Exp Clin Pharmacol 29:19–25
- Kumar P, Padi SSV, Naidu PS, Kumar A. (2006b). Protective effect of antioxidants on 3-nitropropionic acid induced oxidative stress and cognitive impairment. Ann Neurosci 13:41–7
- Kumar P, Padi SSV, Naidu PS, Kumar A. (2007c). 3-Nitropropionic acid induced neurotoxicity: An animal model for Huntington's disease. J Cell Tissue Res 7:853–60
- Luck H. (1971). Catalase. In: Bergmeyer HU, ed. Methods of Enzymatic Analysis. New York: Academic Press, 885–93
- Ludolph AC, He F, Spencer PS, et al. (1991). 3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin. Can J Neurol Sci 18:492–8
- Malik J, Karan M, Vasisht K. (2011). Nootropic, anxiolytic and CNS-depressant studies on different plant sources of shankhpushpi. Pharm Biol 49:1234–42
- Malik J, Kumar M, Deshmukh R, Kumar P. (2013). Ameliorating effect of lyophilized extract of Butea frondosa leaves on scopolamine-induced amnesia in rats. Pharm Biol 51:233–9
- Nahata A, Patil UK, Dixit VK. (2008). Effect of Convolvulus pluricaulis Chois. on learning behaviour and memory enhancement activity in rodents. Nat Prod Res 22:1472–82
- Palfi S, Ferrante RJ, Brouillet E, et al. (1996). Chronic 3-nitropropionic acid treatment in baboons replicates the cognitive and motor deficits of Huntington's disease. J Neurosci 16:3019–25
- Pang Z, Geddes JW. (1997). Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: Acute excitotoxic necrosis and delayed apoptosis. J Neurosci 17:3064–73
- Perez-De La Cruz V, Elinos-Calderon D, Robledo-Arratia Y, et al. (2009). Targeting oxidative/nitrergic stress ameliorates motor impairment, and attenuates synaptic mitochondrial dysfunction and lipid peroxidation in two models of Huntington's disease. Behav Brain Res 199:210–17
- Picconi B, Passino E, Sgobio C, et al. (2006). Plastic and behavioral abnormalities in experimental Huntington's disease: A crucial role for cholinergic interneurons. Neurobiol Dis 22:143–52
- Rodríguez-Martínez E, Rugerio-Vargas C, Rodríguez AI, et al. (2004). Antioxidant effects of taurine, vitamin C, and vitamin E on oxidative damage in hippocampus caused by the administration of 3-nitropropionic acid in rats. Int J Neurosci 114:1133–45
- Saydoff JA, Liu LS, Garcia RA, et al. (2003). Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. Brain Res 994:44–54
- Sharma K, Bhatnagar M, Kulkarni SK. (2010). Effect of Convolvulus pluricaulis Choisy and Asparagus racemosus Willd on learning and memory in young and old mice: A comparative evaluation. Indian J Exp Biol 48:479–85
- Shear DA, Haik KL, Dunbar GL. (2000). Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. Neuroreport 11:1833–7
- Silva RH, Abilio VC, Kameda SR, et al. (2007). Effects of 3-nitropropionic acid administration on memory and hippocampal lipid peroxidation in sleep-deprived mice. Prog Neuropsychopharmacol Biol Psychiatry 31:65–70
- Sinha SN, Dixit VP, Madnawat AVS, Sharma OP. (1989). The possible potentiation of cognitive processing on administration of Convolvulus microphyllus in rats. Indian Med 1:1–6
- Sugino T, Nozaki K, Takagi Y, et al. (1999). Expression and distribution of redox regulatory protein, thioredoxin after metabolic impairment by 3-nitropropionic acid in rat brain. Neurosci Lett 275:145–8
- Tunez I, Santamaria A. (2009). Model of Huntington's disease induced with 3-nitropropionic acid. Rev Neurol 48:430–4
- Vinutha B, Prashanth D, Salma K, et al. (2007). Screening of selected Indian medicinal plants for acetylcholinesterase inhibitory activity. J Ethnopharmacol 109:359–63
- Wills ED. (1966). Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99:667–76